受容体 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "受容体" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

6^th place

146^th place

1guidetopharmacology.org

low place

low place

399^th place

1,603^rd place

1semanticscholar.org

11^th place

1,537^th place

archive.org

Silverman RB (2004). “3.2.C Theories for Drug—Receptor Interactions”. The Organic Chemistry of Drug Design and Drug Action (2nd ed.). Amsterdam: Elsevier Academic Press. ISBN 0-12-643732-7
Waltenbaugh C, Doan T, Melvold R, Viselli S (2008). Immunology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 20. ISBN 978-0-7817-9543-2

doi.org

Gotti, Cecilia; Marks, Michael. J.; Millar, Neil S.; Wonnacott, Susan (16 September 2019). “Nicotinic acetylcholine receptors (version 2019.4)”. IUPHAR/BPS Guide to Pharmacology CITE 2019 (4). doi:10.2218/gtopdb/F76/2019.4 2020年11月17日閲覧。.
Congreve M, Marshall F (March 2010). “The impact of GPCR structures on pharmacology and structure-based drug design”. British Journal of Pharmacology 159 (5): 986–96. doi:10.1111/j.1476-5381.2009.00476.x. PMC 2839258. PMID 19912230.
Qin K, Dong C, Wu G, Lambert NA (August 2011). “Inactive-state preassembly of G(q)-coupled receptors and G(q) heterotrimers”. Nature Chemical Biology 7 (10): 740–7. doi:10.1038/nchembio.642. PMC 3177959. PMID 21873996.
Hamm, Heidi E.; Oldham, William M. (2008). “Heterotrimeric G Protein Activation by G-Protein-Coupled Receptors”. Nature Reviews Molecular Cell Biology (Nature Publishing Group) 9 (1): 60–71. doi:10.1038/nrm2299. PMID 18043707.
Milligan G (December 2003). “Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective”. Molecular Pharmacology 64 (6): 1271–6. doi:10.1124/mol.64.6.1271. PMID 14645655.
Rang, HP (January 2006). “The receptor concept: pharmacology's big idea”. British Journal of Pharmacology 147 Suppl 1: S9-16. doi:10.1038/sj.bjp.0706457. PMC 1760743. PMID 16402126.
Stephenson RP (December 1956). “A modification of receptor theory”. British Journal of Pharmacology and Chemotherapy 11 (4): 379–93. doi:10.1111/j.1476-5381.1956.tb00006.x. PMC 1510558. PMID 13383117.
Boulay G, Chrétien L, Richard DE, Guillemette G (November 1994). “Short-term desensitization of the angiotensin II receptor of bovinde adrenal glomerulosa cells corresponds to a shift from a high to low affinity state”. Endocrinology 135 (5): 2130–6. doi:10.1210/en.135.5.2130. PMID 7956936.

drugs.com

“Curare Drug Information, Professional” (英語). Drugs.com. 2020年12月8日閲覧。

guidetopharmacology.org

Gotti, Cecilia; Marks, Michael. J.; Millar, Neil S.; Wonnacott, Susan (16 September 2019). “Nicotinic acetylcholine receptors (version 2019.4)”. IUPHAR/BPS Guide to Pharmacology CITE 2019 (4). doi:10.2218/gtopdb/F76/2019.4 2020年11月17日閲覧。.

nih.gov

pubmed.ncbi.nlm.nih.gov

Congreve M, Marshall F (March 2010). “The impact of GPCR structures on pharmacology and structure-based drug design”. British Journal of Pharmacology 159 (5): 986–96. doi:10.1111/j.1476-5381.2009.00476.x. PMC 2839258. PMID 19912230.
Qin K, Dong C, Wu G, Lambert NA (August 2011). “Inactive-state preassembly of G(q)-coupled receptors and G(q) heterotrimers”. Nature Chemical Biology 7 (10): 740–7. doi:10.1038/nchembio.642. PMC 3177959. PMID 21873996.
Hamm, Heidi E.; Oldham, William M. (2008). “Heterotrimeric G Protein Activation by G-Protein-Coupled Receptors”. Nature Reviews Molecular Cell Biology (Nature Publishing Group) 9 (1): 60–71. doi:10.1038/nrm2299. PMID 18043707.
Milligan G (December 2003). “Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective”. Molecular Pharmacology 64 (6): 1271–6. doi:10.1124/mol.64.6.1271. PMID 14645655.
Rang, HP (January 2006). “The receptor concept: pharmacology's big idea”. British Journal of Pharmacology 147 Suppl 1: S9-16. doi:10.1038/sj.bjp.0706457. PMC 1760743. PMID 16402126.
Ariens EJ (September 1954). “Affinity and intrinsic activity in the theory of competitive inhibition. I. Problems and theory”. Archives Internationales de Pharmacodynamie et de Therapie 99 (1): 32–49. PMID 13229418.
Stephenson RP (December 1956). “A modification of receptor theory”. British Journal of Pharmacology and Chemotherapy 11 (4): 379–93. doi:10.1111/j.1476-5381.1956.tb00006.x. PMC 1510558. PMID 13383117.
Boulay G, Chrétien L, Richard DE, Guillemette G (November 1994). “Short-term desensitization of the angiotensin II receptor of bovinde adrenal glomerulosa cells corresponds to a shift from a high to low affinity state”. Endocrinology 135 (5): 2130–6. doi:10.1210/en.135.5.2130. PMID 7956936.

ncbi.nlm.nih.gov

Congreve M, Marshall F (March 2010). “The impact of GPCR structures on pharmacology and structure-based drug design”. British Journal of Pharmacology 159 (5): 986–96. doi:10.1111/j.1476-5381.2009.00476.x. PMC 2839258. PMID 19912230.
Qin K, Dong C, Wu G, Lambert NA (August 2011). “Inactive-state preassembly of G(q)-coupled receptors and G(q) heterotrimers”. Nature Chemical Biology 7 (10): 740–7. doi:10.1038/nchembio.642. PMC 3177959. PMID 21873996.
Rang, HP (January 2006). “The receptor concept: pharmacology's big idea”. British Journal of Pharmacology 147 Suppl 1: S9-16. doi:10.1038/sj.bjp.0706457. PMC 1760743. PMID 16402126.
Stephenson RP (December 1956). “A modification of receptor theory”. British Journal of Pharmacology and Chemotherapy 11 (4): 379–93. doi:10.1111/j.1476-5381.1956.tb00006.x. PMC 1510558. PMID 13383117.

semanticscholar.org

Milligan G (December 2003). “Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective”. Molecular Pharmacology 64 (6): 1271–6. doi:10.1124/mol.64.6.1271. PMID 14645655.